We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

26 hedge funds and large institutions have $974K invested in Microbot Medical in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.16% less ownership

Funds ownership: 0.37% → 0.21% (-0.16%)

4% less funds holding

Funds holding: 27 → 26 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

32% less capital invested

Capital invested by funds: $1.44M → $974K (-$461K)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
26
Holders Change
-1
Holders Change %
-3.7%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$62.6K
2
BlackRock
BlackRock
New York
+$15.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1K
4
Invesco
Invesco
Georgia
+$10.1K
5
WS
Wedbush Securities
California
+$1.22K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$612K
2
Citadel Advisors
Citadel Advisors
Florida
-$68.4K
3
TSS
Two Sigma Securities
New York
-$33K
4
AG
Advisor Group
Arizona
-$13.4K
5
UBS Group
UBS Group
Switzerland
-$13.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$366K -$612K -50,314 -60%
Vanguard Group
2
Vanguard Group
Pennsylvania
$348K +$11.1K +915 +3%
VF
3
Virtu Financial
New York
$57K +$62.6K +5,139 New
BlackRock
4
BlackRock
New York
$54K +$15.1K +1,239 +34%
Citadel Advisors
5
Citadel Advisors
Florida
$46K -$68.4K -5,620 -58%
ZCA
6
Zeke Capital Advisors
Pennsylvania
$30K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$26K – – –
Northern Trust
8
Northern Trust
Illinois
$11K – – –
WS
9
Wedbush Securities
California
$9K +$1.22K +100 +15%
Invesco
10
Invesco
Georgia
$9K +$10.1K +828 New
AG
11
Advisor Group
Arizona
$7K -$13.4K -1,100 -63%
UBS Group
12
UBS Group
Switzerland
$7K -$13.2K -1,081 -61%
Wells Fargo
13
Wells Fargo
California
$2K – – –
SPIA
14
Steward Partners Investment Advisory
New York
$1K – – –
Morgan Stanley
15
Morgan Stanley
New York
$1K +$183 +15 +17%
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
$41 – – –
RE
17
RBC Europe
United Kingdom
$2 – – –
TSS
18
Two Sigma Securities
New York
– -$33K -3,222 Closed
GC
19
Guggenheim Capital
Illinois
– -$8K -776 Closed
IWM
20
IHT Wealth Management
Illinois
– -$3K -333 Closed
PFO
21
Pathstone Family Office
New Jersey
– -$243 -20 -80%
Bank of America
22
Bank of America
North Carolina
– -$12 -1 -14%
PCM
23
Poehling Capital Management
Wisconsin
– +$12 +1 New

MBOT Hedge Fund Activity: Q2 2018 in Review

26 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2018, worth a combined $974K — down 32% from $1.44M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MBOT and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $62.6K. The largest seller was Sabby Management, cutting an estimated $612K.

  • 26 institutional investors held Microbot Medical (MBOT) as of Q2 2018, down from 27 in Q1 2018.
  • Funds reported $974K of Microbot Medical stock for Q2 2018, down 32% quarter-over-quarter.
  • 3 funds opened new Microbot Medical positions in Q2 2018 and 4 closed out, a net change of -1 holder.
  • The largest Microbot Medical buyer in Q2 2018 was Virtu Financial, an estimated $62.6K added.
  • The largest Microbot Medical seller in Q2 2018 was Sabby Management, an estimated $612K sold.

Based on aggregated 13F filings for Q2 2018.